WS

Waradana Silva

Pharmaxis Ltd | Non-Executive Director
Mr De Silva is a life sciences investment professional with knowledge of the biotech, pharmaceutical and medical technology sectors. His previous roles include associate healthcare analyst at Macquarie Group covering ASX-listed healthcare companies and lead healthcare analyst at CLSA Australia. Prior to moving into life science investment, he worked at Eli Lilly in various roles focused on the commercialization of new and existing pharmaceuticals.

Companies and Roles

Company
Title
Tenure
Since
PXS
PXS
Pharmaxis Ltd
  • Non-Executive Director
3yrs, 6mthJan 2023
SNT
SNT
Syntara Limited
  • Non-Executive Director
3yrs, 6mthJan 2023

Holdings

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
SNT
SNT
Syntara Limited
30/06/25N/A867,6361,500,000N/A
PXS
PXS
Pharmaxis Ltd
30/06/23N/A867,636N/AN/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
SNT
SNT
Syntara Limited
20/02/25
Issued
9,753,442$0.060$585,206Placement
SNT
SNT
Syntara Limited
23/09/24
Issued
53,571,429$0.028$1,500,000Placement
SNT
SNT
Syntara Limited
13/02/24
Issued
3,000,000$0.022$66,000Issue of options